Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection

• Kai Deng ,

  Contributed equally to this work with: Kai Deng, Ruyu Liu

  Affiliation Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China

  ⨯
• Ruyu Liu ,

  Contributed equally to this work with: Kai Deng, Ruyu Liu

  Affiliation Liver Diseases Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China

  ⨯
• Huiying Rao,

  Affiliation Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China

  ⨯
• Dong Jiang,

  Affiliation Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing Key Laboratory of Emerging infectious Diseases, Beijing, China

  ⨯
• Jianghua Wang,

  Affiliation Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China

  ⨯
• Xingwang Xie,

  Affiliation Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China

  ⨯
• Lai Wei

  * E-mail: weelai@163.com

  Affiliation Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China

  ⨯